Sam Radocchia joined Crypto Token Talk for episode 120 as someone who had actually built enterprise blockchain infrastructure, not pitched it. As co-founder of Chronicled, she spent years deploying distributed ledger technology in pharmaceutical supply chains, the kind of application where the data had legal significance and the parties sharing it had every reason to distrust each other's internal systems. That experience gave her a diagnostic framework for when blockchain was worth using and when it was not. In 2019, when most blockchain commentary was either breathless or dismissive, that kind of operational specificity was rare.
The conversation covered the gap between enterprise blockchain marketing and enterprise blockchain reality. Radocchia had seen both sides. She knew what the consulting firm pitch decks promised and what the actual implementations delivered. Her filter was simple: does this use case involve multiple parties who need to share verified data but cannot trust each other's internal systems? If yes, a distributed ledger may add genuine value. If the answer is a single controlling entity, or parties who already have working API relationships, a conventional database handles it more cheaply and more reliably.
The Coordination Problem Blockchain Actually Solves
Chronicled's pharmaceutical work was a clean illustration of the use cases that hold up. The Drug Supply Chain Security Act required interoperable electronic tracking of prescription drugs across hundreds of manufacturers, distributors, wholesalers, and pharmacies. None of those parties trusted each other's internal data. None of them wanted to hand a single intermediary control over a system that was operationally critical. That is a genuine multi-party coordination problem, exactly the kind where a shared ledger with distributed write access adds something a centralized database cannot.
Cross-border trade documentation had similar characteristics. Multiple entities in different jurisdictions, different legal systems, and different incentive structures needed to share verified records about the same physical goods. The trust problem was structural, not incidental. Radocchia talked about these verticals in operational terms, not theoretical ones, which made the conversation substantially more useful than the analyst-driven use case surveys that dominated coverage at the time.
The National Institute of Standards and Technology published its own blockchain technology overview that covers the same ground from a federal technical perspective. It remains a solid baseline for evaluating enterprise claims, particularly for regulated-industry and public-sector applications.
What the Hype Cycle Got Wrong
By 2019, every major consulting firm had published a report predicting trillions in value from enterprise blockchain adoption. Most of those projections were built on use cases that did not meet the coordination test. Internal logistics platforms controlled by a single company. Data sharing arrangements between parties who already had working relationships and no particular reason to add cryptographic verification overhead. Traceability systems that a barcode scanner and a relational database could handle for a fraction of the cost.
Radocchia was one of the practitioners who could name that problem precisely because she had tried to build products in both categories. She knew which kinds of blockchain deployments were getting killed by integration timelines and organizational politics, and she knew which ones had a compliance-driven forcing function that made them survivable. The distinction was not about the technology. It was about whether the underlying coordination problem justified the cost.
Supply Chain as the Defensible Vertical
The pharmaceutical supply chain argument has aged well. IBM Food Trust built a production network for fresh produce traceability. MediLedger became a live network for pharmaceutical returns and manufacturer verification. The DSCSA compliance deadline created exactly the kind of regulatory pressure that Radocchia described in 2019: a hard requirement that forced multi-party coordination on a fixed timeline, with no option to delay until the technology matured further.
Those projects survived the 2018 to 2020 enterprise blockchain shakeout because they met the coordination test. They had multiple established parties with competing interests, data with genuine legal significance, and a compliance structure that prevented any single party from walking away when the implementation got difficult. The projects that failed had none of those characteristics.
How the Technical Frame Shifted After 2019
The 2019 enterprise blockchain landscape was dominated by permissioned frameworks: Hyperledger Fabric, R3 Corda, Quorum. The assumption was that enterprise deployments required private networks with controlled validators. That framing has loosened considerably since then. Enterprise teams now evaluate Layer 2 rollups on public chains, application-specific chains with privacy layers, and hybrid architectures that combine permissioned settlement with public chain anchoring. The rigid public-versus-private binary that shaped most 2019 conversations has become less analytically useful.
Compliance also shifted from a future problem to a design constraint. The regulatory developments around stablecoins, custodial assets, and on-chain settlement gave technical teams specific requirements to design around, which validated Radocchia's point that compliance-driven verticals were the most durable application space.
About the Guest
Sam Radocchia co-founded Chronicled and built enterprise blockchain infrastructure for pharmaceutical and supply chain applications. She has written and spoken extensively about the gap between blockchain marketing and operational reality, and her perspective is grounded in the specifics of making distributed ledger systems work in regulated industries.